Member Exclusive Longer Read

Polypharmacology of serotonin receptors to treat neurodegenerative diseases

Patrick Dallemagne and Christophe Rochais (Université de Caen Normandie, France) discuss the modulation of several serotonin receptor subtypes and how this could be of interest to treat multifactorial neurodegenerative disease.

Go to the profile of RxNet
Apr 26, 2018

Please sign in or register for FREE

Register to RxNet

RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.